logo
Twitter
Discord
Email
logo
logo
SIGA Technologies, Inc.NASDAQ - SIGA
Reports
Search reports
Name
Reporting Date
Filing Date
2024-09-30 10-Q2024-09-302024-11-07
2024-06-30 10-Q2024-06-302024-08-01
2024-03-31 10-Q2024-03-312024-05-07
2023-12-31 10-K2023-12-312024-03-12
2023-09-30 10-Q2023-09-302023-11-07
2023-06-30 10-Q2023-06-302023-08-08
2023-03-31 10-Q2023-03-312023-05-04
2022-12-31 10-K2022-12-312023-03-02
2022-09-30 10-Q2022-09-302022-11-03
2022-06-30 10-Q2022-06-302022-08-04
2022-03-31 10-Q2022-03-312022-05-05
2021-12-31 10-K2021-12-312022-03-03
2021-09-30 10-Q2021-09-302021-11-04
2021-06-30 10-Q2021-06-302021-08-05
2021-03-31 10-Q2021-03-312021-05-06
2020-12-31 10-K2020-12-312021-03-04
2020-09-30 10-Q2020-09-302020-11-05
2020-06-30 10-Q2020-06-302020-08-06
2020-03-31 10-Q2020-03-312020-05-06
2019-12-31 10-K2019-12-312020-03-05
1
2
20 / page
About
Name
SIGA Technologies, Inc.
Overview
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Show More
CEO
Dr. Dennis E. Hruby Ph.D.
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Listing Date
1997-09-10
Address
31 East 62nd Street, New York, NY, 10065, United States
Tel
212-672-9100
Website
https://www.siga.com